+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell-based Assays Market Size, Share & Trends Analysis Report by End-use (Pharma & Biotech Companies, CROs), by Products & Service (Reagent, Assay Kits), by Application, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • October 2022
  • Region: Global
  • Grand View Research
  • ID: 5681781
The global cell-based assays market is expected to reach USD 33.8 billion by 2030, registering a CAGR of 8.75% over the forecast period. A rise in demand for cell-based assays will drive the market. Cell-based assays effectively aid in acceleration and thereby, enhancement of drug development. This helps therapeutic drugs to be supplied robustly to cater to the industry demand. For instance, these are used in lead candidate selection and provide invaluable information about therapeutic action mechanisms, drug efficacy, safety, and toxicity tests. Wide applications of these assays in drug development processes are expected to boost the demand. These assays are integral to the drug development process by adopting several technologies, such as CRISPR-Cas9, to allow easy resolution of mutations, knock-ins & knockouts of a specific marker at a precise location on the genome or a given culture of cells.

For instance, Celprogen’s human pancreatic cancer cell line characterization kit is a cell-based ELISA kit that is used for the measurement of the concentration of a protein in cells for the determination of the differentiation status of stem cells, thereby eliminating the need to prepare cell lysates and is widely applicable for drug discovery. On the other hand, key players are undertaking various growth strategies to expand their pipelines, portfolios, and offerings to penetrate the market better. For instance, in July 2022, Mission Bio, Inc., launched assay for the detection of solid tumors through its pharma assay development services to aid the acceleration of the development process of cancer therapeutics by reducing the time & cost to characterize solid tumors.

Moreover, in April 2022, Porvair Sciences exhibited Chromatrap chip kits for epigenetics along with a new range of assay and newly designed cell culture microplates for high throughput screening process, cell growth, and proliferation at the American Association for Cancer Research. Many researchers and clinicians believe that there is a strong necessity for novel cell-based assays for their utility in diagnostics and to devise new therapeutic regimes to effectively combat the growing burden of autoimmune diseases, infectious diseases, and genetic disorders across the globe. Furthermore, the COVID?19 pandemic was substantially disruptive both to the continuance of research activities and the type of assays performed.

There are efforts across the U.S. to ensure re-igniting the research activities inclusive of all kinds of cell-based assays. These assays are used for the detection of COVID-19 infection as well. For instance, in May 2020, AcroBiosystem launched a flow cytometry assay to study the binding between ACE2 and S1 protein/S1 RBD protein, thus can be utilized for neutralizing antibody screening. North America dominated the global industry in 2021 owing to an increasing number of biotechnology research studies, growing research on therapeutic drugs, the presence of key players, and the high prevalence of cancer. Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 due to the rising demand for research in life sciences and increased genetic level understanding of diseases.

Cell-based Assays Market Report Highlights

  • The assay kits products segment accounted for the largest revenue share in 2021 due to the utilitarian benefits that a test kit could offer to clinicians, researchers, and the normal population
  • Ready-to-use kits and self-administrable diagnostic kits are increasingly trending these days
  • The drug discovery application segment is expected to grow at a lucrative CAGR over the forecast period
  • This is due to a rise in the number of researches for therapeutic drug discovery, an increasing number of FDA approvals, and a rise in demand for novel therapeutic drugs coupled with increasing cases of genetic disorders, cancers, & infectious diseases
  • The academic & research institutes end-use segment is expected to register the fastest CAGR over the forecast period
  • The growth can be attributed to the greater utility of cell-based assays for the diagnosis of cancers, genetic disorders, and infectious diseases


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.2.1 Information Procurement
1.2.2 Information Analysis
1.2.3 Market Formulation
1.2.4 Validation & Publishing
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 List Of Secondary Sources
1.8 List Of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Market Summary
Chapter 3 Cell Based Assays Market Variables, Trends, & Scope
3.1 Cell Based Assays Market Variables, Trends, and Scope
3.2 Market Driver analysis
3.2.1 Growing Preference For Cell-Based Assays
3.2.2 Increasing Funding For Cell-Based Research
3.2.3 Growing Utilization Of Precision Medicines
3.3 Market Restraint Analysis
3.3.1 HIGH COSTS OF INSTRUMENTS
3.4 Industry Analysis - Porter’s
3.5 SWOT Analysis, by factor (Political & Legal, Economic, and Technological)
Chapter 4 Cell Based Assays Market - Segment Analysis, by Products & Services, 2018 - 2030 (USD Million)
4.1 Cell Based Assays Market: Products & Services Movement Analysis
4.1.1 Reagents
4.1.1.1 Global Reagents Based Cell Based Assays Market, 2018 - 2030 (USD Million)
4.1.2 Assay Kits
4.1.2.1 Global Assay Kits Based Cell Based Assays Market, 2018 - 2030 (USD Million)
4.1.2.2 Cell Growth Assays
4.1.2.2.1 Global Cell Growth Assays Market, 2018 - 2030 (USD Million)
4.1.2.3 Reporter Gene Assays
4.1.2.3.1 Global Reporter Gene Assays Market, 2018 - 2030 (USD Million)
4.1.2.4 Cell Death Assays
4.1.2.4.1 Global Cell Death Assays Market, 2018 - 2030 (USD Million)
4.1.2.5 Second Messenger Assays
4.1.2.5.1 Global Second Messenger Assays Market, 2018 - 2030 (USD Million)
4.1.3 Microplates
4.1.3.1 Global Microplates Based Cell Based Assays Market, 2018 - 2030 (USD Million)
4.1.4 Probes And Labels
4.1.4.1 Global Probes And Labels Based Cell Based Assays Market, 2018 - 2030 (USD Million)
4.1.5 Instruments & Software
4.1.5.1 Global Instruments & Software Based Cell Based Assays Market, 2018 - 2030 (USD Million)
4.1.6 Cell Lines
4.1.6.1 Global Cell Lines Based Cell Based Assays Market, 2018 - 2030 (USD Million)
4.1.6.2 Primary Cell Lines
4.1.6.2.1 Global Primary Cell Lines Market, 2018 - 2030 (USD Million)
4.1.6.3 Stem Cell Lines
4.1.6.2.1 Global Stem Cell Lines Market, 2018 - 2030 (USD Million)
4.1.6.4 Immortalized Cell Lines
4.1.6.2.1 Global immortalized cell lines market, 2018 - 2030 (USD Million)
Chapter 5 Cell Based Assays Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
5.1 Basic Research
5.1.1 Global cell based assays for basic research market, 2018 - 2030 (USD Million)
5.2 Drug Discovery
5.2.1 Global cell based assays for drug discovery market, 2018 - 2030 (USD Million)
5.3 Other Applications
5.3.1 Global cell based assays for other applications, 2018 - 2030 (USD Million)
Chapter 6 Cell Based Assays Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)
6.1 Pharmaceutical & Biotechnology Companies
6.1.1 Global cell based assays for pharmaceutical and biotechnology companies market, 2018 - 2030 (USD Million)
6.2 Academic & Research Institutes
6.2.1 Global cell based assays for academic & research institutes market, 2018 - 2030 (USD Million)
6.3 Contract Research Organizations
6.3.1 Global cell based assays for contract research organizations market, 2018 - 2030 (USD Million)
Chapter 7 Cell Based Assays Market -Regional Business Analysis
7.1 Regional Market Snapshot
7.2 Market Size, & Forecasts, Trend Analysis, 2021 To 2030
7.3 North America
7.3.1 North America Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2 U.S.
7.3.2.1 U.S. Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3 Canada
7.3.3.1 Canada Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4 Europe
7.4.1 Europe Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2 U.K.
7.4.2.1 U.K. Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4 Germany
7.4.4.1 Germany Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5 France
7.4.5.1 France Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6 Italy
7.4.6.1 Italy Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7 Spain
7.4.7.1 Spain Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5 Asia Pacific
7.5.1 Asia-Pacific Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2 Japan
7.5.2.1 Japan Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3 China
7.5.3.1 China Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4 India
7.5.4.1 India Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5 South Korea
7.5.5.1 South Korea Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6 Australia
7.5.6.1 Australia Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6 Latin America
7.6.1 Latin America Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2 Brazil
7.6.2.1 Brazil Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4 Mexico
7.6.4.1 Mexico Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5 Argentina
7.6.5.1 Argentina Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7 Middle East & Africa (MEA)
7.7.1 MEA Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2 South Africa
7.7.2.1 South Africa Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.4 Saudi Arabia
7.7.4.1 Saudi Arabia Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.4 UAE
7.7.4.1 UAE Cell Based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8 Cell Based Assays Market - Competitive Analysis
8.1 Recent Developments & Impact Interpretation, by Key Market Participants
8.1.1 Ansoff Matrix
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.2.3 Key Customers
8.3 Synergy Interpretation: Major Deals & Strategic Alliances
8.3.1 New Product Launch
8.3.2 Acquisition
8.3.3 Expansion
8.3.4 Partnerships
8.3.5 Marketing & Promotions
8.4 Company Profiles
8.4.1 BECTON, DICKINSON AND COMPANY
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 BIO-RAD LABORATORIES, INC.,
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 CORNING INC.,
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 CHARLES RIVER LABORATORIES
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
9.4.5 DANAHER CORPORATION
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.6 HOFFMANN-LA ROCHE LTD. (ROCHE HOLDINGS AG)
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.7 LONZA GROUP AG
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 MERCK KGAA
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.9 PROMEGA CORPORATION
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic initiatives
8.4.10 THERMO FISHER SCIENTIFIC INC.,
8.4.10.1 Company overview
8.4.10.2 Financial performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 4 Global Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 5 Global Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 6 Global Cell Based Assays Market, by Region, 2018-2030 (USD Million)
Table 7 North America Cell Based Assays Market, by Country, 2018-2030 (USD Million)
Table 8 North America Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 9 North America Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 10 North America Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 11 U.S. Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 12 U.S. Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 13 U.S. Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 14 Canada Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 15 Canada Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 16 Canada Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 17 Europe Cell Based Assays Market, by Country, 2018-2030 (USD Million)
Table 18 Europe Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 19 Europe Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 20 Europe Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 21 Germany Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 22 Germany Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 23 Germany Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 24 U.K. Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 25 U.K. Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 26 U.K. Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 27 France Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 28 France Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 29 France Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 30 Italy Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 31 Italy Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 32 Italy Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 33 Spain Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 34 Spain Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 35 Spain Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 36 Asia Pacific Cell Based Assays Market, by Country, 2018-2030 (USD Million)
Table 37 Asia Pacific Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 38 Asia Pacific Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 39 Asia Pacific Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 40 China Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 41 China Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 42 China Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 43 Japan Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 44 Japan Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 45 Japan Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 46 India Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 47 India Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 48 India Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 49 South Korea Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 50 South Korea Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 51 South Korea Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 52 Australia Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 53 Australia Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 54 Australia Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 55 Latin America Cell Based Assays Market, by Country, 2018-2030 (USD Million)
Table 56 Latin America Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 57 Latin America Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 58 Latin America Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 59 Brazil Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 60 Brazil Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 61 Brazil Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 62 Mexico Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 63 Mexico Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 64 Mexico Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 65 Argentina Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 66 Argentina Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 67 Argentina Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 68 Middle East & Africa Cell Based Assays Market, by Country, 2018-2030 (USD Million)
Table 69 Middle East & Africa Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 70 Middle East & Africa Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 71 Middle East & Africa Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 72 South Africa Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 73 South Africa Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 74 South Africa Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 75 Saudi Arabia Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 76 Saudi Arabia Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 77 Saudi Arabia Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
Table 78 UAE Cell Based Assays Market, by Products & Services, 2018-2030 (USD Million)
Table 79 UAE Cell Based Assays Market, by Application, 2018-2030 (USD Million)
Table 80 UAE Cell Based Assays Market, by End Use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Cell based assays market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot 2021 (USD Million)
Fig. 10 Market Trends & Outlook
Fig. 11 Market driver analysis
Fig. 12 Market restraint analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 15 Cell based assays market: Products & services movement analysis
Fig. 16 Global cell based assays reagents market, 2018-2030 (USD Million)
Fig. 17 Global cell based assays kits market, 2018-2030 (USD Million)
Fig. 18 Global cell growth assays market, 2018-2030 (USD Million)
Fig. 19 Global reporter gene assays market, 2018-2030 (USD Million)
Fig. 20 Global cell death assays market, 2018-2030 (USD Million)
Fig. 21 Global second messenger assays market, 2018-2030 (USD Million)
Fig. 22 Global microplates cell based assays market, 2018-2030 (USD Million)
Fig. 23 Global probes and labels cell based assays market, 2018-2030 (USD Million)
Fig. 24 Global instruments & software cell based assays market, 2018-2030 (USD Million)
Fig. 25 Global cell lines assays market, 2018-2030 (USD Million)
Fig. 26 Global primary cell lines market, 2018-2030 (USD Million)
Fig. 27 Global stem cell lines market, 2018-2030 (USD Million)
Fig. 28 Global immortalized cell lines market, 2018-2030 (USD Million)
Fig. 29 Cell based assays market: Application type movement analysis
Fig. 30 Global cell based assays for basic research market, 2018-2030 (USD Million)
Fig. 31 Global cell based assays for drug discovery market, 2018-2030 (USD Million)
Fig. 32 Global cell based assays for other applications, 2018-2030 (USD Million)
Fig. 33 Cell based assays market: End use movement analysis
Fig. 34 Global cell based assays for pharmaceutical and biotechnology companies market, 2018-2030 (USD Million)
Fig. 35 Global cell based assays for academic & research institutes market, 2018-2030 (USD Million)
Fig. 36 Global cell based assays for contract research organizations market, 2018-2030 (USD Million)
Fig. 37 Cell based assays market: Regional movement analysis
Fig. 38 North America cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 39 U.S. cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 40 Canada cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 41 Europe cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 42 U.K. cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 43 Germany cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 44 France cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 45 Italy cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 46 Spain cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 47 Asia-Pacific cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 48 Japan cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 49 China cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 50 India cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 51 South Korea cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 52 Australia cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 53 Latin America cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 54 Brazil cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 55 Mexico cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 56 Argentina cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 57 MEA cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 58 South Africa cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 59 Saudi Arabia cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 60 UAE cell based assays market estimates and forecast, 2018-2030 (USD Million)
Fig. 61 Ansoff Matrix

Companies Mentioned

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning Inc.
  • Charles River Laboratories
  • Danaher Corporation
  • Hoffmann-La Roche Ltd. (Roche Holdings Ag)
  • Lonza Group AG
  • Merck Kgaa
  • Promega Corporation
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information